Your browser doesn't support javascript.
loading
Stimuli-responsive nanoformulations for CRISPR-Cas9 genome editing.
Fang, Tianxu; Cao, Xiaona; Ibnat, Mysha; Chen, Guojun.
Affiliation
  • Fang T; Department of Biomedical Engineering, McGill University, Montreal, QC, H3G 0B1, Canada.
  • Cao X; Rosalind & Morris Goodman Cancer Institute, McGill University, Montreal, QC, H3G 0B1, Canada.
  • Ibnat M; Department of Biomedical Engineering, McGill University, Montreal, QC, H3G 0B1, Canada.
  • Chen G; Rosalind & Morris Goodman Cancer Institute, McGill University, Montreal, QC, H3G 0B1, Canada.
J Nanobiotechnology ; 20(1): 354, 2022 Aug 02.
Article in En | MEDLINE | ID: mdl-35918694
ABSTRACT
The CRISPR-Cas9 technology has changed the landscape of genome editing and has demonstrated extraordinary potential for treating otherwise incurable diseases. Engineering strategies to enable efficient intracellular delivery of CRISPR-Cas9 components has been a central theme for broadening the impact of the CRISPR-Cas9 technology. Various non-viral delivery systems for CRISPR-Cas9 have been investigated given their favorable safety profiles over viral systems. Many recent efforts have been focused on the development of stimuli-responsive non-viral CRISPR-Cas9 delivery systems, with the goal of achieving efficient and precise genome editing. Stimuli-responsive nanoplatforms are capable of sensing and responding to particular triggers, such as innate biological cues and external stimuli, for controlled CRISPR-Cas9 genome editing. In this Review, we overview the recent advances in stimuli-responsive nanoformulations for CRISPR-Cas9 delivery, highlight the rationale of stimuli and formulation designs, and summarize their biomedical applications.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Language: En Journal: J Nanobiotechnology Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Language: En Journal: J Nanobiotechnology Year: 2022 Document type: Article Affiliation country: